knowledge -WSS

knowledge

author：knowledge 2025-09-30 00:39:33 - browse：88187

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How to protect patients from sexual assault

Wikipedia

WSS

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Medicaid rebukes states for mistakenly disenrolling children

Why Novartis is changing the name of its research labs

A letter from the executive editor: The 2023 STATUS List

NIH nominee Bertagnolli will get October confirmation hearing

Beware reading your test results before your doctor does

entertainment

knowledge

knowledge

Medical leaders decry Supreme Court decision on affirmative action

The wait for US passports is creating travel purgatory and snarling summer plans

New air purifier tech could be key to improving indoor air quality

The 10 drugs up first for Medicare price negotiation

Hollywood unions extend contract negotiations for actors

Lupron, used to halt puberty in children, may cause lasting health problems

At least 13 dead in Texas as scorching temps continue

The 10 drugs up first for Medicare price negotiation

As demand for Covid shots wanes, Moderna seeks its next success

Covid hospitalizations on the rise, Humana says

entertainment

Amazon on where the company's health care bets are headed next

What American doctors can learn from their Israeli counterparts

Beware reading your test results before your doctor does

Snackable artificial intelligence, expert AI, and the pharma industry

How to fix cancer clinical trials' diversity problem

Beware reading your test results before your doctor does

leisure time

explore

Wikipedia

focus